Cart
sales@molnova.com
Lyn-IN-1
CAS No. 887650-05-7
Lyn-IN-1( —— )
Catalog No. M16418 CAS No. 887650-05-7
Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 59 | Get Quote |
|
| 5MG | 88 | Get Quote |
|
| 10MG | 159 | Get Quote |
|
| 25MG | 296 | Get Quote |
|
| 50MG | 501 | Get Quote |
|
| 100MG | 618 | Get Quote |
|
| 200MG | 860 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLyn-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionLyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.
-
DescriptionLyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetBcr-Abl
-
RecptorBcr-Abl
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number887650-05-7
-
Formula Weight576.6154
-
Molecular FormulaC30H31F3N8O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=C(C=N4)C5=CN=CN=C5
-
Chemical NameBenzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. From PCT Int.Appl.(2014), WO2014169128A1
molnova catalog
related products
-
Vamotinib
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis.
-
DCC-2036
DCC-2036 (Rebastinib) is a highly potent, non-ATP-competitive BCR-ABL1 inhibitor with IC50 of 0.8 and 4 nM for native ABL1 and gatekeeper mutant ABL1 T315I, respectively.
-
GMB-475
GMB-475 is a BCR-ABL1 tyrosine kinase degrader based on PROTAC, overcoming BCR-ABL1-dependent drug resistance.
